Stay updated on Ravulizumab Study in LN/IgAN Clinical Trial
Sign up to get notified when there's something new on the Ravulizumab Study in LN/IgAN Clinical Trial page.

Latest updates to the Ravulizumab Study in LN/IgAN Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3. This indicates a new page release rather than a change to the study details.SummaryDifference0.0%

- Check23 days agoChange DetectedThe page now lists Revision: v3.6.2 as the current document version, replacing Revision: v3.6.0. This indicates an update to the study-related documents linked on the page.SummaryDifference0.0%

- Check38 days agoChange DetectedAdded a recruitment status note indicating the study is no longer enrolling. Added new help sections to guide users on reading the study record and how to join a study.SummaryDifference0.3%

- Check45 days agoChange DetectedA new page revision v3.5.5 has been posted, superseding the previous v3.5.4. This reflects a minor update to the page content or formatting rather than any changes to study details.SummaryDifference0.0%

- Check66 days agoChange DetectedA new revision label v3.5.4 was added for the Study Protocol document, replacing the previous v3.5.3.SummaryDifference0.1%

- Check87 days agoChange DetectedThe page’s displayed site/version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a minor platform update rather than a change to the clinical trial record.SummaryDifference0.0%

Stay in the know with updates to Ravulizumab Study in LN/IgAN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ravulizumab Study in LN/IgAN Clinical Trial page.